JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping Posted on January 12, 2021 by Nile JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping esagonowsky Tue, 01/12/2021 – 10:40 Share this:TwitterFacebookLike this:Like Loading...